These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21356294)

  • 1. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain.
    Ved PM; Kim K
    Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits.
    Yu H; Kim K
    Int J Pharm; 2009 Aug; 378(1-2):73-9. PubMed ID: 19501141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits.
    Kaur P; Kim K
    Int J Pharm; 2008 Nov; 364(1):27-35. PubMed ID: 18760341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
    Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
    J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting.
    Jose S; Ansa CR; Cinu TA; Chacko AJ; Aleykutty NA; Ferreira SV; Souto EB
    Int J Pharm; 2013 Jan; 441(1-2):516-26. PubMed ID: 23147411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Blatta orientalis (Q) nasal gel formulation in milk aspiration induced eosinophilia.
    Nimgulkar CC; Patil SD; Chauk DS
    Pharm Dev Technol; 2009; 14(4):435-41. PubMed ID: 19552565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
    Gupta S; Samanta MK
    Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
    Shi S; Wu J; Dai W; Li C; Ge W
    Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
    Sharma S; Lohan S; Murthy RS
    Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain distribution of ribavirin after intranasal administration.
    Colombo G; Lorenzini L; Zironi E; Galligioni V; Sonvico F; Balducci AG; Pagliuca G; Giuliani A; Calzà L; Scagliarini A
    Antiviral Res; 2011 Dec; 92(3):408-14. PubMed ID: 22001322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel.
    Chen X; Zhi F; Jia X; Zhang X; Ambardekar R; Meng Z; Paradkar AR; Hu Y; Yang Y
    J Pharm Pharmacol; 2013 Jun; 65(6):807-16. PubMed ID: 23647674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of nimodipine in brain following intranasal administration in rats.
    Zhang QZ; Jiang XG; Wu CH
    Acta Pharmacol Sin; 2004 Apr; 25(4):522-7. PubMed ID: 15066224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide.
    Yuan Y; Cui Y; Zhang L; Zhu HP; Guo YS; Zhong B; Hu X; Zhang L; Wang XH; Chen L
    Int J Pharm; 2012 Jul; 430(1-2):114-9. PubMed ID: 22503953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
    Thorne RG; Pronk GJ; Padmanabhan V; Frey WH
    Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nose-to-brain delivery of tacrine.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
    Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
    J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal delivery of ESBA105, a TNF-alpha-inhibitory scFv antibody fragment to the brain.
    Furrer E; Hulmann V; Urech DM
    J Neuroimmunol; 2009 Oct; 215(1-2):65-72. PubMed ID: 19733918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
    Khan S; Patil K; Yeole P; Gaikwad R
    J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.